These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15215151)

  • 21. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children.
    Dagan R; Leibovitz E; Fliss DM; Leiberman A; Jacobs MR; Craig W; Yagupsky P
    Antimicrob Agents Chemother; 2000 Jan; 44(1):43-50. PubMed ID: 10602721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.
    Ibar-Bariain M; Rodríguez-Gascón A; Isla A; Solinís MA; Canut-Blasco A
    Rev Esp Quimioter; 2019 Apr; 32(2):121-129. PubMed ID: 30727714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae.
    Bottenfield GW; Burch DJ; Hedrick JA; Schaten R; Rowinski CA; Davies JT
    Pediatr Infect Dis J; 1998 Oct; 17(10):963-8. PubMed ID: 9802654
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of azithromycin and amoxicillin/clavulanate for otitis media in children: a systematic review and meta-analysis of randomized controlled trials.
    Dawit G; Mequanent S; Makonnen E
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):28. PubMed ID: 33894769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Otitis media.
    Pichichero ME
    Pediatr Clin North Am; 2013 Apr; 60(2):391-407. PubMed ID: 23481107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility.
    Hoberman A; Paradise JL; Block S; Burch DJ; Jacobs MR; Balanescu MI
    Pediatr Infect Dis J; 1996 Oct; 15(10):955-62. PubMed ID: 8895940
    [No Abstract]   [Full Text] [Related]  

  • 28. Are cephalosporins appropriate for the treatment of acute otitis media in this era of increasing antimicrobial resistance among common respiratory tract pathogens?
    Appelbaum PC
    Clin Pediatr (Phila); 2005 Mar; 44(2):95-107. PubMed ID: 15735827
    [No Abstract]   [Full Text] [Related]  

  • 29. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
    Casellas JM; Israele V; Marín M; Ishida MT; Heguilen R; Soutric J; Arenoso H; Sibbald A; Stamboulian D
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1225-33. PubMed ID: 16061111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Smith JL; Shouse T; Davis P; McCracken GH
    Clin Infect Dis; 2002 May; 34(10):1301-9. PubMed ID: 11981724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate.
    Brook I; Gober AE
    J Med Microbiol; 2005 Jun; 54(Pt 6):553-556. PubMed ID: 15888464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy.
    Ghaffar F; Friedland IR; Katz K; Muniz LS; Smith JL; Davis P; Reynolds J; McCracken GH
    J Pediatr; 1999 Nov; 135(5):618-23. PubMed ID: 10547251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections.
    Krishnan P; Rajendran P; Sambandan AP; Anitha C; Chavda RK; Khobragade KJ
    J Indian Med Assoc; 2011 Apr; 109(4):241-2, 244. PubMed ID: 22187795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant organisms and otitis media.
    Dagan R; Regev-Yochay G; Rubinstein E
    Pediatr Infect Dis J; 2005 Sep; 24(9):849; author reply 849-51. PubMed ID: 16148862
    [No Abstract]   [Full Text] [Related]  

  • 36. [Microbiological evaluation of effectiveness of antibacterial drugs for the acute inflammation of the middle ear].
    Klein JO
    Pediatr Pol; 1995 Jan; 70(1):91-4. PubMed ID: 7624178
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management.
    Marchisio P; Claut L; Rognoni A; Esposito S; Passali D; Bellussi L; Drago L; Pozzi G; Mannelli S; Schito G; Principi N
    Pediatr Infect Dis J; 2003 Mar; 22(3):262-8. PubMed ID: 12634589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of potassium clavulanate/amoxicillin (CLAVAMOX) dry syrup in children with otitis media].
    Sugita R; Yamanaka N; Kudo F; Ito R; Kawai M; Ohwaki I; Asano S; Nagata T
    Jpn J Antibiot; 2007 Aug; 60(4):221-41. PubMed ID: 18018419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bacterial flora in children with recurrent acute otitis media].
    Zielnik-Jurkiewicz B; Kolczyńska M
    Pol Merkur Lekarski; 2005 Feb; 18(104):146-50. PubMed ID: 17877118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.